http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#Head http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#assertion http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#provenance http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#pubInfo http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#assertion https://uts.nlm.nih.gov/uts/umls/concept/C0449297 http://wordnet-rdf.princeton.edu/lemma/integrate https://uts.nlm.nih.gov/uts/umls/concept/C0015264 http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#provenance http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#assertion http://www.w3.org/ns/prov#generatedAtTime 2021-12-16T19:30:41.578749 http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC project version 2 http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#version http://www.w3.org/ns/prov#value 2 http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT http://www.w3.org/2000/01/rdf-schema#label into the final PK / PD model, ", where dexamethasone ( DEX ) exerted dexamethasone ( DEX ) s antitumor efficacy by inhibiting the proliferation of tumor cells", enhanced dexamethasone ( DEX ) responses by decreasing the sensitivity parameter EC(50 ) http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label 60 http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE http://www.w3.org/2000/01/rdf-schema#label integrated http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION http://www.w3.org/2000/01/rdf-schema#label [154] http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT http://www.w3.org/2000/01/rdf-schema#label The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label 144 http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:wdxnfuun&rows=50 wdxnfuun http://www.w3.org/2000/01/rdf-schema#SENTENCE http://www.w3.org/2000/01/rdf-schema#label The PK model of dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) as well as that of dexamethasone (DEX) with a time-dependent clearance were integrated into the final PK/PD model both using Hill’s function, where dexamethasone (DEX) exerted dexamethasone (DEX)'s antitumor efficacy by inhibiting the proliferation of tumor cells, and dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) enhanced dexamethasone (DEX) responses by decreasing the sensitivity parameter EC(50). http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:wdxnfuun-TRIPLE-ABSTRACT-10 wdxnfuun-TRIPLE-ABSTRACT-10 https://uts.nlm.nih.gov/uts/umls/concept/C0015264 http://www.w3.org/2000/01/rdf-schema#label exerted https://uts.nlm.nih.gov/uts/umls/concept/C0449297 http://www.w3.org/2000/01/rdf-schema#label clearance http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#pubInfo http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#assertion http://www.w3.org/ns/prov#wasDerivedFrom https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470835/ http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#sig http://purl.org/nanopub/x/hasSignature MW0mftc/3giX9u6jOJFZwBGuIaLs0suFerkP28MbNhqB12pweKIPaP/0T3MHppWxq0tszyke7v39JNELvVY+dfDWfd4R5ZDj5+/A5pex3Dls1JN4CDcyNjnylRV/w65EPRXpe2e09jQDDkjZSdhQnzBu763ycnzKsaFWr0UW/vo= http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow http://www.w3.org/ns/prov#generatedAtTime 2021-12-16T19:30:41.578749 http://purl.org/np/RAkuMr8Tc0DxHaqIe6Ke54BALgCoC5K-Qoo6J4_Ttcsow http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-8954-0470